retatrutide nonalcoholic fatty liver disease nash trial A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis Mechanisms of NAFLD development and

While convenient for those who dont like injections, the absorption of oral semaglutide is generally lower than injectable forms

Retatrutide vs Mounjaro also varies in availability because Retatrutide remains in clinical development and Mounjaro already holds prescribing approval for type 2 diabetes

"The comment period for the proposed rule closed on June 18, 2024," an FDA spokesperson wrote in an email to NPR

In people with type 2 diabetes and advanced-stage CKD who have obesity and exceed body mass index limits required for kidney transplantation, the use of GLP-1 receptor agonists has been suggested to aid with weight loss, which may then facilitate eligibility for transplantation